We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Honda
HMC
$39.1B
| $206K | ﹤0.01% |
7,906
-53,095
| -87% | -$1.34M |
|
3727
iShares MSCI EAFE Value ETF
EFV
$28.8B
| $205K | ﹤0.01% |
4,319
-9,167
| -68% | -$427K |
|
|
SOLY
3728
DELISTED
Soliton, Inc.
SOLY
| $205K | ﹤0.01% |
19,144
+2,740
| +17% | +$35.3K |
|
3729
Standard BioTools
LAB
$340M
| $204K | ﹤0.01% |
44,199
-71,843
| -62% | -$566K |
|
3730
NN Inc
NNBR
$255M
| $204K | ﹤0.01% |
28,626
+3,371
| +13% | +$25.3K |
|
3731
Puma Biotechnology
PBYI
$404M
| $204K | ﹤0.01% |
18,945
+281
| +2% | +$3.03K |
|
|
NEX
3732
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $203K | ﹤0.01% |
33,640
-931,529
| -97% | -$5.46M |
|
3733
Willdan Group
WLDN
$1.04B
| $201K | ﹤0.01% |
5,728
+74
| +1% | +$2.64K |
|
3734
Canadian Solar
CSIQ
$1.02B
| $200K | ﹤0.01% |
+10,587
| New | +$230K |
|
3735
Byline Bancorp
BY
$1.78B
| $199K | ﹤0.01% |
11,201
-1,014
| -8% | -$18.4K |
|
|
SPNS
3736
DELISTED
Sapiens International
SPNS
| $199K | ﹤0.01% |
10,157
-132
| -1% | -$2.31K |
|
|
ECOM
3737
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $198K | ﹤0.01% |
21,225
+4,995
| +31% | +$45.9K |
|
3738
Orion
OEC
$381M
| $197K | ﹤0.01% |
+11,796
| New | +$193K |
|
|
CLVS
3739
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $197K | ﹤0.01% |
50,000
| – | – |
|
|
EARN
3740
Ellington Residential Mortgage REIT
EARN
$162M
| $195K | ﹤0.01% |
18,503
+5,040
| +37% | +$54.2K |
|
3741
Geron
GERN
$828M
| $195K | ﹤0.01% |
146,449
+9,951
| +7% | +$13.3K |
|
3742
Arlo Technologies
ARLO
$1.6B
| $194K | ﹤0.01% |
56,884
+1,438
| +3% | +$5.22K |
|
|
MHN
3743
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $191K | ﹤0.01% |
14,000
| – | – |
|
|
FIT
3744
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $191K | ﹤0.01% |
+50,000
| New | +$186K |
|
|
HPR
3745
DELISTED
HighPoint Resources Corporation
HPR
| $188K | ﹤0.01% |
2,372
+199
| +9% | +$13.8K |
|
|
DVAX
3746
DELISTED
Dynavax Technologies
DVAX
| $187K | ﹤0.01% |
52,613
+8,277
| +19% | +$32.1K |
|
|
SWIR
3747
DELISTED
Sierra Wireless
SWIR
| $187K | ﹤0.01% |
17,490
+808
| +5% | +$9.21K |
|
3748
Green Brick Partners
GRBK
$3.04B
| $186K | ﹤0.01% |
17,421
+1,210
| +7% | +$11.6K |
|
|
FRGI
3749
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $186K | ﹤0.01% |
17,817
-456
| -2% | -$4.76K |
|
|
AKCA
3750
DELISTED
Akcea Therapeutics Inc
AKCA
| $186K | ﹤0.01% |
12,085
-2,545
| -17% | -$54.2K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.